Innoviva, Inc. share price logo

Innoviva, Inc. Share Price

NASDAQ: INVA

Small Cap

$19.38

-0.05

(-0.26%)

as on

Innoviva, Inc. Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $19.16
    $19.48
    downward going graph

    1.14%

    Downside

    0.52%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $16.67
    $22
    downward going graph

    13.98%

    Downside

    13.52%

    Upside

    downward going graph

Innoviva, Inc. share price movements today

Previous Close
$19.43
Open
$19.38
Volume
440.6K
Day's Low - High
$19.16 - $19.48
52 Week Low - High
$16.67 - $22

Innoviva, Inc. Historical Returns

1 Month Return
-5.73 %
3 Month Return
-10.42 %
1 Year Return
-1.92 %
3 Year Return
+ 51.68 %
5 Year Return
+ 69.4 %

Innoviva, Inc. Stock Fundamentals & Key Indicators

Check Innoviva, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2B

EPS (TTM)

1.8

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.63%

PE Ratio (TTM)

33.98

Industry PE ratio

-3.773885542168675

P/B Ratio

33.9825

PEG Ratio

0.2285

EBITDA

206.9M

Revenue (TTM)

370.2M

Profit Margin

10.44%

Return On Equity TTM

5.60%

Innoviva, Inc. Stock Valuation

Track how Innoviva, Inc. P/E has moved over time to understand its valuation trends.

Innoviva, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (4.11x)

September 30, 2022

Industry (-3.77x)

September 13, 2025

Today (33.98x)

September 13, 2025

Highest (101.06x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 33.98x

Innoviva, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Innoviva, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
SELL$1.2B69.4%33.9810.44%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Innoviva, Inc. Stock including INR - Dollar returns

The Innoviva, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Innoviva, Inc. investment value today

Current value as on today

₹1,02,968

Returns

₹2,968

(+2.97%)

Returns from Innoviva, Inc. Stock

₹2,171 (-2.17%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Innoviva, Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Innoviva, Inc.. Average target price of $41

Innoviva, Inc. Share Price Target

Get share price movements and forecasts by analysts on Innoviva, Inc..

What analysts predicted

52.73%UPSIDE

Target Price

$41

Current Price

$19.38

Analyzed by

6 Analysts

Target

$41.00

Innoviva, Inc. target price $41, a slight upside of 52.73% compared to current price of $19.38. According to 6 analysts rating.

Innoviva, Inc. Stock's Interest Amongst Investors

Search interest for Innoviva, Inc. Stock has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-7% versus previous 30 day period

Innoviva, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
76
80
67
89
80
103
89
91
88
100
Gross Profit
66
72
57
66
60
84
79
78
79
89
Operating Income
47
10
90
37
25
54
49
43
-41
-48
EBITDA
54
19
100
44
60
-23
19
35
-27
83
Interest Expense
4
4
4
5
5
5
5
4
4
4
Depreciation
3
8
9
-3
6
6
6
6
6
6
Income Before Tax
41
5
85
61
45
-39
6
24
-38
72
Income Tax Expense
6
4
3
0
8
-4
5
4
7
8
Net Income
34
1
82
61
36
-34
1
20
-46
63
Net Profit Margin
45.65%
1.58%
121.99%
68.93%
45.13%
-33.56%
1.36%
22.15%
-52.56%
63.51%

Innoviva, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
53
133
217
261
261
336
391
331
310
358
Gross Profit
51
132
217
261
261
0
391
317
261
322
Operating Income
31
108
183
238
246
321
375
209
176
166
EBITDA
46
125
191
236
231
317
361
322
248
99
Interest Expense
51
52
43
23
18
18
19
15
19
22
Depreciation
-
-
13
13
13
13
13
5
33
25
Income Before Tax
-18
59
134
210
232
354
445
286
194
37
Income Tax Expense
50
49
0
-196
41
60
76
66
14
13
Net Income
-18
59
134
395
157
224
265
213
179
23
Net Profit Margin
-34.77%
44.57%
61.76%
151.36%
60.26%
66.63%
67.84%
64.56%
57.89%
6.52%

Innoviva, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
1
82
61
36
-34
1
20
-46
63
Operating Cash Flow
38
43
33
37
43
48
59
48
44
Investing Cash Flow
-17
-25
-5
-43
-
-5
-15
-34
33
Financing Cash Flow
-9
-11
-14
-9
-5
0
0
0
1
Change in Cash
28
6
13
-15
38
43
44
14
78

Innoviva, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
59
134
406
190
293
368
220
179
23
Operating Cash Flow
60
141
223
257
313
363
201
141
188
Investing Cash Flow
-4
-23
3
-18
-314
43
-56
-66
-63
Financing Cash Flow
-97
-163
-237
-23
-29
-452
-55
-171
-13
Change in Cash
-41
-44
-10
215
-31
-44
89
-97
111

Global Institutional Holdings in Innoviva, Inc.

Funds
Holdings
BlackRock Inc
14.62%
Vanguard Group Inc
9.99%
Dimensional Fund Advisors, Inc.
7.39%
Renaissance Technologies Corp
7.23%
Franklin Resources Inc
6.3%

Insights on Innoviva, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -46.58M → 63.68M (in $), with an average increase of 173.1% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 88.63M → 100.28M (in $), with an average increase of 11.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 77.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 68.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, INVA stock has moved down by -5.3%

About Innoviva, Inc.

innoviva is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. innoviva's portfolio is anchored by the respiratory assets partnered with glaxo group limited (gsk), including relvar®/breo® ellipta® and anoro® ellipta®, which were jointly developed by innoviva and gsk. under the agreement with gsk, innoviva is eligible to receive associated royalty revenues from relvar®/breo® ellipta®, anoro® ellipta® and, if approved and commercialized, vi monotherapy, as well. in addition, innoviva retains a 15 percent economic interest in future payments made by gsk for earlier-stage programs partnered with theravance biopharma, inc. for more information, please visit innoviva's website at www.inva.com.
OrganisationInnoviva, Inc.
Headquarters1350 Old Bayshore Highway, Burlingame, CA, United States, 94010
IndustryHealth Technology
CEOMr. Pavel Raifeld C.F.A.
E-voting on sharesClick here to vote

Key Management of Innoviva, Inc.

Name

Title

Ms. Patricia M. Drake

Chief Commercial Officer-Innoviva Specialty Therapeutics, Inc.

Dr. David Altarac M.D., MPA

Chief Medical Officer of IST

Mr. Pavel Raifeld C.F.A.

CEO & Director

Mr. Stephen Basso M.B.A.

Chief Financial Officer

Ms. Marianne Zhen CPA

Chief Accounting Officer & Secretary

Ms. Marcie Cain

Chief People Officer

FAQs

What is Innoviva, Inc. share price today?

Innoviva, Inc. share price today is $19.38 as on at the close of the market. Innoviva, Inc. share today touched a day high of $19.48 and a low of $19.16.

What is the 52 week high and 52 week low for Innoviva, Inc. share?

Innoviva, Inc. share touched a 52 week high of $22 on and a 52 week low of $16.67 on . Innoviva, Inc. stock price today i.e. is closed at $19.38,which is 11.91% down from its 52 week high and 16.26% up from its 52 week low.

What is Innoviva, Inc.'s market capitalisation today?

Innoviva, Inc. market capitalisation is $0.00T as on .

How to invest in Innoviva, Inc. Stock (INVA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Innoviva, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Innoviva, Inc. Shares that will get you 0.0774 shares as per Innoviva, Inc. share price of $19.38 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Innoviva, Inc. Stock (INVA) from India?

Indian investors can start investing in Innoviva, Inc. (INVA) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Innoviva, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Innoviva, Inc. share’s latest price of $19.38 as on September 13, 2025 at 1:29 am IST, you will get 0.5160 shares of Innoviva, Inc.. Learn more about fractional shares .

What are the returns that Innoviva, Inc. has given to Indian investors in the last 5 years?

Innoviva, Inc. stock has given 69.4% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?